|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Penas-Prado M, Armstrong S and Gilbert MR:
Glioblastoma. Handb Clin Neurol. 105:485–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith JS, Brachmann CB, Celic I, Kenna MA,
Muhammad S, Starai VJ, Avalos JL, Escalante-Semerena JC, Grubmeyer
C, Wolberger C and Boeke JD: A phylogenetically conserved
NAD+-dependent protein deacetylase activity in the Sir2 protein
family. Proc Natl Acad Sci USA. 97:6658–6663. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu T, Liu PY and Marshall GM: The
critical role of the class III histone deacetylase SIRT1 in cancer.
Cancer Res. 69:1702–1705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin SJ, Defossez PA and Guarente L:
Requirement of NAD and SIR2 for life-span extension by calorie
restriction in Saccharomyces cerevisiae. Science. 289:2126–2128.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo J, Nikolaev AY, Imai S, Chen D, Su F,
Shiloh A, Guarente L and Gu W: Negative control of p53 by Sir2alpha
promotes cell survival under stress. Cell. 107:137–148. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaziri H, Dessain SK, Ng Eaton E, Imai SI,
Frye RA, Pandita TK, Guarente L and Weinberg RA: hSIR2(SIRT1)
functions as an NAD-dependent p53 deacetylase. Cell. 107:149–159.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim CS: Human SIRT1: A potential biomarker
for tumorigenesis? Cell Biol Int. 31:636–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi HN, Bae JS, Jamiyandorj U, Noh SJ,
Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG and Moon WS: Expression
and role of SIRT1 in hepatocellular carcinoma. Oncol Rep.
26:503–510. 2011.PubMed/NCBI
|
|
11
|
Holloway KR, Calhoun TN, Saxena M, Metoyer
CF, Kandler EF, Rivera CA and Pruitt K: SIRT1 regulates Dishevelled
proteins and promotes transient and constitutive Wnt signaling.
Proc Natl Acad Sci USA. 107:9216–9221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Zhang M, Dong H, Yong S, Li X,
Olashaw N, Kruk PA, Cheng JQ, Bai W, Chen J, et al: Deacetylation
of cortactin by SIRT1 promotes cell migration. Oncogene.
28:445–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Firestein R, Blander G, Michan S,
Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S,
de Cabo R, Fuchs C, et al: The SIRT1 deacetylase suppresses
intestinal tumorigenesis and colon cancer growth. PLoS One.
3:e20202008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pruitt K, Zinn RL, Ohm JE, McGarvey KM,
Kang SH, Watkins DN, Herman JG and Baylin SB: Inhibition of SIRT1
reactivates silenced cancer genes without loss of promoter DNA
hypermethylation. PLoS Genet. 2:e402006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeung F, Hoberg JE, Ramsey CS, Keller MD,
Jones DR, Frye RA and Mayo MW: Modulation of NF-kappaB-dependent
transcription and cell survival by the SIRT1 deacetylase. EMBO J.
23:2369–2380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chua KF, Mostoslavsky R, Lombard DB, Pang
WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N,
et al: Mammalian SIRT1 limits replicative life span in response to
chronic genotoxic stress. Cell Metab. 2:67–76. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zavadil J, Haley J, Kalluri R, Muthuswamy
SK and Thompson E: Epithelial-mesenchymal transition. Cancer Res.
68:9574–9577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyazono K: Transforming growth factor-β
signaling and cancer: The 28th sapporo cancer seminar, 25–27 June
2008. Cancer Sci. 100:363–365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui Y, Li J, Zheng F, Ouyang Y, Chen X,
Zhang L, Chen Y, Wang L, Mu S and Zhang H: Effect of SIRT1 Gene on
epithelial-mesenchymal transition of human prostate cancer PC-3
Cells. Med Sci Monit. 22:380–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng F, Su L, Yao C, Liu L, Shen J, Liu
C, Chen X, Luo Y, Jiang L, Shan J, et al: SIRT1 promotes
epithelial-mesenchymal transition and metastasis in colorectal
cancer by regulating Fra-1 expression. Cancer Lett. 375:274–283.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simic P, Williams EO, Bell EL, Gong JJ,
Bonkowski M and Guarente L: SIRT1 suppresses the
epithelial-to-mesenchymal transition in cancer metastasis and organ
fibrosis. Cell Rep. 3:1175–1186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee M, Kim DW, Yoon H, So D, Khalmuratova
R, Rhee CS, Park JW and Shin HW: Sirtuin 1 attenuates nasal
polypogenesis by suppressing epithelial-to-mesenchymal transition.
J Allergy Clin Immunol. 137:87–98.e7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu Y, Zhang J, Wu S, Li B, Liu S and Cheng
J: SIRT1 promotes proliferation and inhibits apoptosis of human
malignant glioma cell lines. Neurosci Lett. 525:168–172. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JS, Park JR, Kwon OS, Lee TH, Nakano
I, Miyoshi H, Chun KH, Park MJ, Lee HJ, Kim SU and Cha HJ: SIRT1 is
required for oncogenic transformation of neural stem cells and for
the survival of ‘cancer cells with neural stemness’ in a
p53-dependent manner. Neuro Oncol. 17:95–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu WB, Wang W, Du YH, Li H, Xia SJ and Liu
HT: MicroRNA-3713 regulates bladder cell invasion via MMP9. Sci
Rep. 6:323742016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun T, Fu J, Shen T, Lin X, Liao L, Feng
XH and Xu J: The Small C-terminal domain phosphatase 1 inhibits
cancer cell migration and invasion by dephosphorylating
Ser(P)68-Twist1 to accelerate Twist1 protein degradation. J Biol
Chem. 291:11518–11528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ford J, Jiang M and Milner J:
Cancer-specific functions of SIRT1 enable human epithelial cancer
cell growth and survival. Cancer Res. 65:10457–10463. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Long X, Chao C, Yan C, Wu Q, Hua S,
Zhang Y, Wu A and Fang W: Knocking down CDK4 mediates the elevation
of let-7c suppressing cell growth in nasopharyngeal carcinoma. BMC
Cancer. 14:2742014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Qu Q, Qu J, Luo WM, Wang SY, He YZ,
Luo QS, Xu YX and Wang YF: Association between XRCC1 polymorphisms
and glioma risk among Chinese population. Med Oncol. 31:1862014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sai K, Zhong MG, Wang J, Chen YS, Mou YG,
Ke C, Zhang XH, Yang QY, Lin FH, Guo CC, et al: Safety evaluation
of high-dose BCNU-loaded biodegradable implants in Chinese patients
with recurrent malignant gliomas. J Neurol Sci. 343:60–65. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou Q: WHO classification of tumors of
central nervous system (2007): An introduction. Zhonghua Bing Li
Xue Za Zhi. 37:5–7. 2008.(In Chinese). PubMed/NCBI
|
|
34
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bosch-Presegué L and Vaquero A: The dual
role of sirtuins in cancer. Genes Cancer. 2:648–662. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Hokka D, Maniwa Y, Ohbayashi C,
Itoh T and Hayashi Y: Sirt1 is a tumor promoter in lung
adenocarcinoma. Oncol Lett. 8:387–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu DF, Jiang SJ, Pan ZP, Cheng WD, Zhang
WJ, Yao XK, Li YC and Lun YZ: Expression and clinical significance
of Sirt1 in colorectal cancer. Oncol Lett. 11:1167–1172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oon CE, Strell C, Yeong KY, Östman A and
Prakash J: SIRT1 inhibition in pancreatic cancer models:
Contrasting effects in vitro and in vivo. Eur J Pharmacol.
757:59–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yuan F, Liu L, Lei Y and Tang P: p53
inhibits the upregulation of sirtuin 1 expression induced by c-Myc.
Oncol Lett. 14:4396–4402. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
41
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu ZJ, Liu HL, Zhou HC and Wang GC: TIPE2
Inhibits Hypoxia-Induced Wnt/β-catenin pathway activation and EMT
in glioma cells. Oncol Res. 24:255–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Z, Wu Y, Wang Y, Jin Y, Ma X, Zhang Y
and Ren H: Matrine inhibits the invasive properties of human glioma
cells by regulating epithelial-to-mesenchymal transition. Mol Med
Rep. 11:3682–3686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Byles V, Zhu L, Lovaas JD, Chmilewski LK,
Wang J, Faller DV and Dai Y: SIRT1 induces EMT by cooperating with
EMT transcription factors and enhances prostate cancer cell
migration and metastasis. Oncogene. 31:4619–4629. 2012. View Article : Google Scholar : PubMed/NCBI
|
